ArticleGynecologic oncology reports2025

Efficacy of pembrolizumab in combination with bevacizumab and oral metronomic cyclophosphamide in the treatment of platinum resistant recurrent ovarian cancer: a retrospective observational study.

Alexandra R Steck et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.